Coverage dated December 1, 2025 to December 2, 2025
Shingles vaccine may slow the progress of dementia, new study finds
Headline from Delaware Public Media
Scientists believe the shingles vaccine may slow down the progression of symptoms.
Delaware Public Media's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
A large follow-up study has found that shingles vaccination may protect against risks at different stages of dementia — including for people already diagnosed.
An unusual public health policy in Wales may have produced the strongest evidence yet that a vaccine can reduce the risk of dementia. In a new study led by Stanford Medicine, researchers analyzing the health records of Welsh older adults discovered that those who received the shingles vaccine were 2…
The shingles vaccine not only offers protection against the painful viral infection, but a new study suggests that the two-dose shot also may slow the progression of dementia.
Stanford Medicine researchers found that older adults who received the shingles vaccine were 20% less likely to develop dementia over the next seven years.
The Shingles vaccine may slow down its progression of dementia, new research shows. The study builds on earlier research that found that the shot also may prevent the development of dementia.
Shingles vaccine may slow the progress of dementia, new study finds | Since Then
